Arthritis

• Most adults in later life experience some form of ill health, such as arthritis, cognitive impairment, heart problems or issues with hearing and vision.
• The problem is that the UK housing stock is nowhere near ready to cater to this need.
• And yet, there were more than 20,000 people on English local authority waiting lists for wheelchair and accessible homes.

The impact of poor housing

• And size matters: the smaller the house, the more difficult it is for those people with disabilities to move around and live fulfilled lives.
• As journalists Melissa York and Georgia Lambert put it in 2023:
  Poor quality housing costs the NHS £1.4 billion a year, yet the relationship between housing and health is rarely acknowledged.
• Poor quality housing costs the NHS £1.4 billion a year, yet the relationship between housing and health is rarely acknowledged.
• Poor housing is routinely cited as a major cause.

Why we need supportive housing design

• Built environment professionals, including architects, stress the importance of reimagining housing design by establishing Part M Clause 2 (category 2) of the Building Regulations as the baseline to better support healthy ageing.
• A 90-year-old great-grandmother can live independently if her home features wide doorways, no-step entrances and a walk-in shower with grab bars.

• The John Morden Centre in Blackheath, London, illustrates how thoughtful design can support older residents’ quality of life.
• Of course, ideas need to be put into practice for them to really change the way people live.
• In construction terms, this means that supportive design needs to be enshrined in building regulations and the wider housing policy.
• Making such design regulations compulsory would see the housing industry effectively contribute to reducing the burden on the NHS and our social care system.
• Architects talk about resilient housing to describe homes that are built for the long-term with sustainable healthy ageing in mind.

Faye Sedgewick receives funding from Innovate UK and is a member of the Architects Registration Board. Paul Jones receives funding from Innovate UK, Research England, AHRC

• NEW YORK, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced the acquisition of all the issued and outstanding common shares of Aimia Pet Healthco Inc. (‘Aimia’).
• Better Choice will now be in a position to manage the clinical trials internally in hopes to develop a supplement to support weight loss in domestic animals.
• More than half of all dogs and cats worldwide are classified as overweight or obese and can suffer from the same weight-related health complications as humans – including arthritis, diabetes, and high blood pressure.
• Following the successful creation by Pfizer of its Slentrol medication, Better Choice will work with Aimia to develop treats and toppers to safely combat pet obesity.

• Dr. Barnard shows that certain foods actually cause weight loss, like a weight-loss medication without a prescription.
• The Power Foods Diet , by Balance Publishing, is available for preorder now and will be on bookshelves everywhere March 26.
• “In reality, the best solution for reaching and maintaining a healthy weight is a low-fat plant-based diet that excludes animal products.
• Two women who each lost 100 pounds following the plan are featured in the book.

• WINDCREST, Texas, Feb. 5, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Thomas Nathan Hoffmann, MD is acknowledged as a Pinnacle Lifetime Member for his contributions in Rheumatology.
• His holistic approach to healthcare has earned him recognition and trust among patients seeking a better quality of life.
• His dual board certification in internal medicine and rheumatology reflects his commitment to providing the highest standard of care to his patients.
• Dr. Hoffmann is board-certified in both internal medicine and rheumatology, holding Diplomate status with the American Board of Internal Medicine (ABIM).